Skip to main content

and
  1. No Access

    Article

    Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study

    N. Gossai, D. Bhojwani, E. S. Schafer, B. H. Chang, L. Pommert, A. Verma in Leukemia (2023)